Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Natural product preferentially targets redox and metabolic adaptations and aberrantly active STAT3 to inhibit breast tumor growth in vivo. | Cell Death Dis | 2022 | 36473850 | PubTator, text mining | PubMed |
| Systems biology reveals anatabine to be an NRF2 activator. | Front Pharmacol | 2022 | 36467029 | PubTator, text mining | PubMed |
| Drosophila SUMM4 complex couples insulator function and DNA replication control. | Elife | 2022 | 36458689 | PubTator, text mining | PubMed |
| Corrigendum: Current insights into the regulation of programmed cell death by TP53 mutation in cancer. | Front Oncol | 2022 | 36439483 | PubTator, text mining | PubMed |
| The role of TIGAR in nervous system diseases. | Front Aging Neurosci | 2022 | 36437984 | PubTator, text mining | PubMed |
| Role of ferroptosis-associated genes in ankylosing spondylitis and immune cell infiltration. | Front Genet | 2022 | 36437923 | PubTator, text mining | PubMed |
| Engineering tumor-specific catalytic nanosystem for NIR-II photothermal-augmented and synergistic starvation/chemodynamic nanotherapy. | Biomater Res | 2022 | 36435848 | PubTator, text mining | PubMed |
| Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD-L1 in Triple-Negative Breast Cancer Cells. | Nutrients | 2022 | 36432484 | PubTator, text mining | PubMed |
| Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF. | Cells | 2022 | 36429010 | PubTator, text mining | PubMed |
| Construction of Oxidative Stress-Related Genes Risk Model Predicts the Prognosis of Uterine Corpus Endometrial Cancer Patients. | Cancers (Basel) | 2022 | 36428665 | PubTator, text mining | PubMed |
| Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification. | Cancers (Basel) | 2022 | 36428646 | PubTator, text mining | PubMed |
| Selenium and Redox Enzyme Activity in Pregnant Women Exposed to Methylmercury. | Antioxidants (Basel) | 2022 | 36421477 | PubTator, text mining | PubMed |
| On the Potential Role of the Antioxidant Couple Vitamin E/Selenium Taken by the Oral Route in Skin and Hair Health. | Antioxidants (Basel) | 2022 | 36421456 | PubTator, text mining | PubMed |
| Resistance Training Modulates Reticulum Endoplasmic Stress, Independent of Oxidative and Inflammatory Responses, in Elderly People. | Antioxidants (Basel) | 2022 | 36421428 | PubTator, text mining | PubMed |
| Combined Targeting of the Glutathione and Thioredoxin Antioxidant Systems in Pancreatic Cancer. | ACS Pharmacol Transl Sci | 2022 | 36407947 | PubTator, text mining | PubMed |
| Pharmacological and analytical aspects of alkannin/shikonin and their derivatives: An update from 2008 to 2022. | Chin Herb Med | 2022 | 36405061 | PubTator, text mining | PubMed |
| Transcriptome profile and its partly verification of human hepatocellular carcinoma cells exposed to Yuzhizi () seed extract. | J Tradit Chin Med | 2022 | 36378050 | PubTator, text mining | PubMed |
| The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer. | Cell Commun Signal | 2022 | 36376959 | PubTator, text mining | PubMed |
| Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer. | Sci Rep | 2022 | 36371529 | PubTator, text mining | PubMed |
| Antibodies-Abzymes with Antioxidant Activities in Two Th and 2D2 Experimental Autoimmune Encephalomyelitis Mice during the Development of EAE Pathology. | Molecules | 2022 | 36364362 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=45